Does this solve the right problem?
Connect the product to a funded operational priority, measurable outcome, and accountable executive owner.
This is one track within Production Assurance, not a separate consulting portfolio. It focuses the same operating evidence on a vendor or commercial commitment.

Health systems often compare polished demonstrations without a shared method for determining whether the solution fits the workflow, creates value, changes human workload, and can be governed after the pilot.
Connect the product to a funded operational priority, measurable outcome, and accountable executive owner.
Map the people, decisions, systems, data, exceptions, and downstream work affected by the solution.
Identify the assumptions, limitations, validation gaps, and local evidence required before confidence is justified.
Estimate capacity, labor, throughput, delay, revenue, quality, adoption, and hidden review burden.
Define the population, workflow, baseline, metrics, acceptance criteria, intervention rules, and scale conditions.
Give leadership a direct recommendation with unresolved conditions and a defensible decision record.
The commercial decision begins where the free trial ends. The buyer still has to know what value is required at the quoted price, which implementation and review costs were hidden, how much adoption is needed, and what evidence would trigger conversion, renegotiation, extension, or decline.
The engagement fits a platform comparison, a specialized vendor review, a pilot design, or a scale decision for a system already in use.
Assess where Microsoft Copilot, OpenAI, Claude, or other enterprise platforms fit the organization’s operating model and where specialized workflows are justified.
Evaluate patient access, revenue cycle, utilization management, ambient, diagnostic support, workflow automation, and other AI products against local requirements.
Determine whether a promising demonstration has produced credible operating evidence or merely shown that users like the concept.
Identify duplication, architectural gaps, integration burden, inconsistent success criteria, and where a platform or workflow strategy is needed.
The work can focus on one vendor, competing options, or an existing pilot approaching a commercial decision.
Define the operating problem, decision points, affected roles, systems, evidence, and desired outcome.
Compare stated capability, validation, limitations, integration, operating assumptions, and responsibilities.
Specify population, baseline, metrics, exceptions, human workload, controls, and scale thresholds.
Provide a clear decision, negotiation priorities, unresolved conditions, and recommended next engagement.
Do not ask only whether the vendor’s AI is competent. Ask whether the organization can responsibly use it in this workflow.
The missing question is whether the product changed the decision and the work enough to justify the price.
A strong vendor decision separates an impressive demonstration from the evidence needed for production.
It is most useful before a major purchase, during a contested vendor selection, or when a pilot is approaching a scale decision. The work clarifies the operating problem, the claims that matter, the proof the pilot must produce, and the decision leadership must make.
No. The engagement evaluates fit against the organization’s workflow, evidence, constraints, and desired outcomes. The result is an organization-specific recommendation and a clearer basis for negotiation, testing, acceptance, or rejection.
A pilot should prove more than model performance or a successful demonstration. It should show how the workflow performs under realistic conditions, how exceptions and handoffs work, who holds authority, what value is created, and how failure or recovery will be managed.
Bring the vendor, proposed use, pilot status, and the commercial decision leadership must make.
Research and practical analysis on AI products, agentic systems, production assurance, governance, and decision control. Published by Dr. Amit K. Shah.